Accueil / Tag Archives: Contract/Agreement

Tag Archives: Contract/Agreement

Insulet prendra en charge la distribution et l’assistance commerciale de son système Omnipod® en Europe

Friday, July 21st 2017 at 2:27am UTC La distribution directe contribue à la solidité et à la croissance de la clientèle européenne et renforce les perspectives financières de la société BILLERICA, Massachusetts–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet ou la Société), le chef de file de la technologie de pompe …

Plus »

Hocoma and Saebo Partner to Deliver Compact, Affordable Rehabilitation Solution for Upper Extremities

Monday, July 17th 2017 at 2:00pm UTC ZURICH & CHARLOTTE, N.C.–(BUSINESS WIRE)– Hocoma and Saebo today announced a partnership to improve the training possibilities for patients with moderate to mild impairments of the upper extremities. Together, the SaeboMas Mini and the ArmeoSenso deliver an easy-to-use, compact solution at an affordable …

Plus »

Immune Pharmaceuticals Provides Update on Plan to Implement a Spin-off of Cytovia into a Separate Publicly Traded Oncology Company

Wednesday, July 19th 2017 at 1:32pm UTC Immune shareholders to receive additional pro rata shares in Cytovia NEW YORK–(BUSINESS WIRE)– Immune Pharmaceuticals (NASDAQ: IMNP) (“Immune”) today confirmed it is continuing to structure and pursue a spin-off of Cytovia, Inc. (“Cytovia”), its subsidiary dedicated to the development and commercialization of Oncology …

Plus »

LSGPA Invests an Additional $500,000 in MacuLogix, Inc.

Tuesday, July 18th 2017 at 8:54pm UTC Developer of FDA-Cleared AdaptDx® to Aid Diagnosis and Monitoring of Age-Related Macular Degeneration (AMD) HARRISBURG, Pa.–(BUSINESS WIRE)– The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) announced today an additional investment of $500,000 in MacuLogix, Inc. The investment was part of a syndicate with …

Plus »

OncLive® and Targeted Oncology™ Partner with the Association of Community Cancer Centers

Tuesday, July 18th 2017 at 1:34pm UTC OncLive® continues to expand Strategic Alliance Partnership program CRANBURY, N.J.–(BUSINESS WIRE)– OncLive® and Targeted Oncology™ are proud to announce they’ve partnered with the Association of Community Cancer Centers (ACCC) as a part of its Strategic Alliance Partnership (SAP) program, announced Michael J. Hennessy …

Plus »

Prana Commences Research Collaboration with Takeda for the Treatment of Parkinson’s Disease Gastrointestinal Neuropathology

Tuesday, July 18th 2017 at 1:00pm UTC PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture MELBOURNE, Australia & SAN FRANCISCO–(BUSINESS WIRE)– Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced a research collaboration with Takeda Pharmaceuticals International, Inc. to study the ability of Prana’s investigational …

Plus »

New partnership between Christiana Care’s Gene Editing Institute and NovellusDx speeds progress toward personalized cancer medicine

Thursday, July 20th 2017 at 1:02pm UTC WILMINGTON, Del.–(BUSINESS WIRE)– Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx. The Gene …

Plus »

ABL Awarded NIH Contract for HIV Vaccine Development Worth up to $318 Million

Wednesday, July 19th 2017 at 2:05pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– ABL, Inc. (ABL), a global contract research and manufacturing service provider, announced today it has been awarded the recompetition of the contract for “Preclinical Development Support” (Contract # HHSN272201700010I) by the Division of AIDS (DAIDS) within the National Institute of …

Plus »

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

Tuesday, July 18th 2017 at 6:12am UTC Telix to develop products for imaging and treatment of prostate cancer CAMBRIDGE, England & MELBOURNE, Australia–(BUSINESS WIRE)– Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licence …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...